Source: Michigan Medicine Health Lab Less than one year after stepping away from acting due to a diagnosis of aphasia, Bruce Willis has been diagnosed with frontotemporal dementia, according to a[…]
The Michigan Alzheimer’s Disease Research Center (MADRC), funded by the NIH/National Institute on Aging, is pleased to announce openings in its Early Career Investigator Mentorship Program in the MADRC Research[…]
On January 6, 2023, the FDA granted accelerated approval to Lecanemab (Leqembi). The drug shows a biological effect in removing a hallmark of Alzheimer’s disease pathology, beta-amyloid in individuals with[…]
Find the competition space posting available here. We are pleased to announce the launch of Michigan Alzheimer’s Disease Center Developmental Project Program. Internal Submission Deadline: Friday, December 2, 2022 Cycle:[…]
The Alzheimer’s Association International Conference is a time for researchers to come together to share the latest research on Alzheimer’s Disease. This year, the conference took place in San Diego,[…]
Research into critical areas of dementia is made possible at our center by donor gifts. This past winter, we received a generous donation from the family of one of our[…]
A Wellness Note excerpt from Laura Rice-Oeschger, LMSW. To receive regular wellness notes, please subscribe to our monthly wellness e-newsletter here. Ten years ago this month we hosted the first[…]
We are pleased to offer a mentoring program for junior investigators. The program aims to provide junior investigators entering the field of dementia research with a broad education about contemporary[…]